Integra Q4 revenue $405.5M (+8.3% organic); adj EPS $0.84 flat; guides FY2022 adj EPS $3.27-3.35

INTEGRA LIFESCIENCES HOLDINGS CORP

2021-FY EPS reported $1.98 revenue$1,542,448,000

Q4 reported revenue $405.5M (+4.3% reported, +8.3% organic); GAAP EPS $0.53 vs $1.09 (prior-year $59.2M tax benefit); adjusted EPS $0.84 flat.
Full-year 2021 revenue $1,542.4M (+12.4% reported, +14.2% organic); GAAP EPS $1.98 vs $1.57; adjusted EPS $3.18 vs $2.45.
Q4 Codman Specialty Surgical organic growth +9.0%; Tissue Technologies organic +6.7%.
FY2022 guidance: revenue $1,580-1,600M (organic +3.5-5%); adjusted EPS $3.27-3.35; Q1 revenue $357-365M, adj EPS $0.67-0.71.
Entered $125M accelerated share repurchase on Jan 12, 2022, expected to complete in H1 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.